Free Trial
LON:MHC

MyHealthChecked (MHC) Share Price, News & Analysis

MyHealthChecked logo
GBX 13.20 -0.80 (-5.71%)
As of 04/17/2025 03:33 AM Eastern

About MyHealthChecked Stock (LON:MHC)

Key Stats

Today's Range
13.20
14
50-Day Range
13
19
52-Week Range
8
21
Volume
12,528 shs
Average Volume
48,766 shs
Market Capitalization
£6.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Receive MHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyHealthChecked and its competitors with MarketBeat's FREE daily newsletter.

MHC Stock News Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Oberon AIM VCT Ord (OVCT.L)
Returns At MyHealthChecked (LON:MHC) Are On The Way Up
See More Headlines

MHC Stock Analysis - Frequently Asked Questions

MyHealthChecked's stock was trading at GBX 12.50 at the beginning of the year. Since then, MHC stock has increased by 5.6% and is now trading at GBX 13.20.
View the best growth stocks for 2025 here
.

Shares of MHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MyHealthChecked investors own include Beowulf Mining (BEM), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Gresham House Strategic (GHS) and Greencore Group (GNC).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:MHC
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-1,043,292.17
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.43 million
Cash Flow
GBX 7.42 per share
Price / Cash Flow
1.78
Book Value
GBX 14.54 per share
Price / Book
0.91

Miscellaneous

Free Float
N/A
Market Cap
£6.87 million
Optionable
Not Optionable
Beta
1.37
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:MHC) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners